Aptevo Therapeutics Inc.
APVO
$4.83
-$0.02-0.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 71.00K | -- |
| Gross Profit | -- | -- | -- | -71.00K | -- |
| SG&A Expenses | 2.46M | 3.57M | 2.90M | 2.85M | 2.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -345.00K | -- | -- | -- | -- |
| Total Operating Expenses | 11.65M | 7.61M | 6.23M | 6.48M | 6.38M |
| Operating Income | -11.65M | -7.61M | -6.23M | -6.48M | -6.38M |
| Income Before Tax | -5.81M | -7.55M | -6.20M | -6.41M | -6.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.81M | -7.55M | -6.20M | -6.41M | -6.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.81M | -7.55M | -6.20M | -6.41M | -6.31M |
| EBIT | -11.65M | -7.61M | -6.23M | -6.48M | -6.38M |
| EBITDA | -11.49M | -7.56M | -6.18M | -6.42M | -6.31M |
| EPS Basic | -10.81 | -40.13 | -151.29 | -- | -- |
| Normalized Basic EPS | -3.84 | -20.97 | -94.55 | -- | -- |
| EPS Diluted | -10.81 | -40.13 | -151.29 | -- | -- |
| Normalized Diluted EPS | -3.84 | -20.97 | -94.55 | -- | -- |
| Average Basic Shares Outstanding | 946.20K | 224.90K | 41.00K | -- | -- |
| Average Diluted Shares Outstanding | 946.20K | 224.90K | 41.00K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |